TAPINAROF CREAM IMPROVED ITCH IN TWO PHASE 3 TRIALS OF MODERATE TO SEVERE ATOPIC DERMATITIS

被引:0
|
作者
Silverberg, J.
Boguniewicz, M.
Rubenstein, D.
Tallman, A.
Brown, P.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P282
引用
收藏
页码:S90 / S90
页数:1
相关论文
共 50 条
  • [31] Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
    Simpson, E. L.
    Bieber, T.
    Guttman-Yassky, E.
    Beck, L. A.
    Blauvelt, A.
    Cork, M. J.
    Silverberg, J. I.
    Deleuran, M.
    Kataoka, Y.
    Lacour, J. -P.
    Kingo, K.
    Worm, M.
    Poulin, Y.
    Wollenberg, A.
    Soo, Y.
    Graham, N. M. H.
    Pirozzi, G.
    Akinlade, B.
    Staudinger, H.
    Mastey, V.
    Eckert, L.
    Gadkari, A.
    Stahl, N.
    Yancopoulos, G. D.
    Ardeleanu, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24): : 2335 - 2348
  • [32] Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
    Simpson, Eric L.
    Akinlade, Bolanle
    Ardeleanu, Marius
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11): : 1090 - 1091
  • [33] Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials
    Kosloski, Matthew P.
    Guttman-Yassky, Emma
    Cork, Michael J.
    Worm, Margitta
    Nahm, Dong-Ho
    Zhu, Xiaoping
    Ruddy, Marcella K.
    Harel, Sivan
    Kamal, Mohamed A.
    Goulaouic, Helene
    Xu, Christine R.
    Avetisova, Elena
    Davis, John D.
    Nivens, Michael C.
    Shabbir, Arsalan
    Radin, Allen
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
  • [34] Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan L.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Micahel E.
    Venturanza, May E.
    Wei, Shaoceng
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 651 - 653
  • [35] Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results
    Maeda-Chubachi, Tomoko
    Johnson, Lakshmi Vasist
    Bullman, Jonathan
    Collingwood, Therese
    Bissonnette, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB247 - AB247
  • [36] Dupilumab elicits rapid and sustained improvements in itch in adults with moderate-to-severe atopic dermatitis
    Silverberg, J. I.
    Eckert, L.
    Yosipovitch, G.
    Kim, B.
    Simpson, E. L.
    Rossi, A. B.
    Ardeleanu, M.
    Chen, Z.
    Kaur, M.
    Gadkari, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S105 - S105
  • [37] Upadacitinib for moderate to severe atopic dermatitis
    Navarro-Trivino, Francisco
    Alcantara-Luna, Sara
    Dominguez-Cruz, Javier
    Galan-Gutierrez, Manuel
    Ruiz-Villaverde, Ricardo
    Pereyra-Rodriguez, Jose-Juan
    Armario-Hita, Jose-Carlos
    IMMUNOTHERAPY, 2023, 15 (11) : 799 - 808
  • [38] Herpes virus infections amongst moderate to severe atopic dermatitis patients treated with baricitinib: an integrated analysis of phase 3 trials
    Werfel, T.
    Irvine, A. D.
    Bangert, C.
    Seneschal, J.
    Grond, S.
    Cardillo, T.
    Brinker, D.
    Zhong, J.
    Riedl, E.
    Wollenberg, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S162 - S162
  • [39] A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis
    Peppers, Johnny
    Paller, Amy S.
    Maeda-Chubachi, Tomoko
    Wu, Sterling
    Robbins, Kevin
    Gallagher, Kelly
    Kraus, John E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 89 - +
  • [40] Treatment of atopic dermatitis with tapinarof cream: secondary outcomes from a phase IIb randomized parallel-group study
    Paller, A.
    Rubenstein, D.
    Tallman, A. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E115 - E116